Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1810.38	1747.85	91.49
Graham Fair Price	59.84	2928.46	1832.16
PEG	-31.73	0.18	-0.26
Price/Book	57.47	0.91	0.58
Price/Cash Flow	-61.52	46.84	-121.71
Prices/Earnings	-37.93	27.69	44.62
Price/Sales	52.07	2.71	1.78
Price/FCF	-61.52	46.84	-121.71
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	31.30	0.10	0.08
Operating Margin	-90.08	< 0.005	-0.01
ROA	148.27	< 0.005	< 0.005
ROE	< 0.005	< 0.005	153.71
ROIC	< 0.005	< 0.005	-91.68
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.00	-0.24	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.57	1.10	93.24
EPS QOQ	1.70	1.55	-9.09
FCF QOQ	0.80	5.11	536.64
Revenue QOQ	0.26	0.04	-85.09
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	42.76	44.90	5.01
Days Sales Outstanding (DSO)	42.37	42.89	1.24
Inventory Turnover	2.10	2.00	-4.77
Debt/Capitalization	< 0.005	< 0.005	-0.35
Quick Ratio	2.03	1.92	-5.31
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6775.65	6799.20	0.35
Cash	1896.20	2044.36	7.81
Capex	-112.04	-25.91	76.88
Free Cash Flow	-32.29	132.59	310.61
Revenue	2204.04	2290.22	3.91
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.71	2.57	-5.16
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.94	-106.23	-1689.22
Naive Interpretation	Member

06 - Financial Health · Bad

Rating